Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis)

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 6 - Best Posters in preventive cardiology Percutaneous Coronary Intervention (PCI) and Surgery ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by